Archivio Storico

Branded vs Generic: The Saga Continues

The Pharmacist Perspective

Laurie Scudder, DNP, NP

Nov 29, 2012 MedScapeNews

Brand-Name vs Generic Agents: The Pharmacist Experience

Pharmacists, prescribers, and patients often voice concerns about the safety and efficacy of generic drugs that are substituted for brand-name drug products. No matter where they fall on the spectrum, most clinicians, however, acknowledge that they are here to stay. The US Food and Drug Administration (FDA) approves a generic substitute if it has proven to be "identical, or bioequivalent, to a brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use." [1]

The FDA’s Orange Book provides the latest information on generic approvals. Approved generic agents have been demonstrated to have therapeutic equivalence — although many clinicians have questioned whether that equivalence extends to all patients and all clinical scenarios. Jenny

Articoli correlati

Pulsante per tornare all'inizio
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco